Timeline of our history

Milenia Biotec is dedicated to the devel­opment, manufac­turing and sales of point-​​of care lateral flow tests, a technology well known from pregnancy testing. The core products of the company are based on „universal test strips“, a concept allowing quick and simple devel­op­ments and a simple production process. Milenia Biotec is located in Gießen, a university city with 84.000 inhab­i­tants, 45% of them are students. Gießen is in the center of Germany, 60 km north of Frankfurt/​Main with its inter­na­tional airport. From here we serve our customers worldwide direct or via our network of partners and distrib­utors.
2000

Founding

Milenia has been founded by private share­holders in Bad Nauheim. The city, located in the center of Germany, is a spa primarily dedicated to health care since centuries.

2001

QuickLine IL-​​6

Milenia QuickLine IL-​​6, the first kit allowing a true point-​​of-​​care measurement of IL-​​6, has been launched by Milenia Biotec. The kit helped neona­tol­o­gists worldwide to improve the diagnosis of sepsis in preterm born infants and to create the basis to reduce unnec­essary antibiotic treat­ments and unnec­essary admis­sions to neonatal intensive care wards.

2003

PicoScan

PicoScan has been intro­duced to the market and allowed the (semi-​​) quanti­tative measure­ments of the Milenia QuickLine IL-​​6.

2003

HybriDetect

Milenia HybriDetect, has been released and became a core product of the company. Milenia HybriDetect is a universal lateral flow strip and serves for any developer as a simple rapid test devel­opment platform.

2003

ISO Certi­fi­cation

Milenia Biotec success­fully passed the first ISO audit by TÜV Rheinland and was granted a ISO certificate according to EN ISO 13485.

2005

HybriDetect 2T

Milenia HybriDetect 2T has been released to the market. The product allows the detection of two analytes on the same strip and is intended to be used for duplex testing in molecular biology based methods.

2006

First HybriDetect Publi­cation

The first scien­tific paper citing the use of Milenia HybriDetect in a molecular biology based method has been published by Piepenburg O. et al.

2008

Move to Gießen

Milenia Biotec moves from Bad Nauheim to Gießen, a university city with 84.000 inhab­i­tants, 45% of them are students. The university of Gießen/​Marburg with its medical faculty is in the close vicinity of the company.

2008

POCScan

The POCScan instrument for the point-​​of-​​care measurement of Milenias lateral flow tests has been launched. It is the first true stand alone instrument available from Milenia Biotec. The first quanti­tative test available on POScan is Milenia QuickLine IL-​​6.

2010

Gun Shot Residues

Milenias project „Detection of gun shot residues with a simple lateral flow test“ has been selected by the funding agency AiF as 1 of the 12 most innov­ative projects for their 2011 calender. AiF has selected the projects from more than 10.000 funded projects.

2011

Antigen and Antibody Devel­opment

Milenia Biotec opens an own R&D group dedicated to the devel­opment of antigens and antibodies.

2011

QuickLine HIT

Milenia QuickLine HIT has been launched to the market. The test allows the exclusion of a heparin induced throm­bo­cy­topenia in patients at a suspision of a HIT on a very high level of sensi­tivity and speci­ficity.

2012

Bio-​​DrIM Network

Milenia Biotec joins the Bio-​​DrIM consortium, a group of European univer­sities and companies dealing with the biomarker driven person­alized immuno­sup­pression in trans­plant patients.

2012

Medical App Devel­opment

Milenia Biotec opens an own R&D group dedicated to the devel­opment of medical apps.

2013

ProAn­i­malLife Network

Milenia joins Network ProAn­i­malLife.

2013

More Office Space

Milenia expands office floor space of the company building.

2014

Molecular Biology Test Devel­opment

Milenia Biotec opens R&D group dedicated to the devel­opment of molecular biology based PCR tests. The first project is the devel­opment of a series of PCR-​​tests for the detection of beer spoilage bacteria. All tests are based on Milenia HybriDetect our universal strip devel­opment platform.

2015

Innovation Award to Cooper­ation Partner

German Brewers Associ­ation grants Innovation Award to Jennifer Koob, cooper­ation partner of Milenia in the project „Detection of beer spoilage bacteria with a simple lateral flow test“.

2016

GenLine Detection of Beer Spoilage Bacteria

GenLine tests for the detection of beer spoilage bacteria launched to the market.

2017

GenLine Detection of Alicy­clobacilli

Milenia GenLine Alicy­clobacillus tests are launched to the market.

2017

Virus­Detect Project

Milenia receives research grants for the project „Virus­Detect“. The project is the contri­bution of Milenia to the network ProAn­i­malLife.

2017

First HybriDetect CRISPR Paper

First CRISPR based paper citing the use of Milenia HybriDetect published.

2018

GenLine Hygien­emon­i­toring

GenLine Hygien­emon­i­toring launched to the market.

2020

Innovation Seal

Stifter­verband grants innovation seal to Milenia Biotec.

2020

Milenia on LinkedIn

Milenia Biotec launches company page on LinkedIn.

2020

HybriDetect and SARS-​​CoV-​​2

Milenia HybriDetect used in a series of papers for the detection of SARS-​​CoV-​​2.

2020

145 HybriDetect Publi­ca­tions

2000

Founding

Milenia has been founded by private share­holders in Bad Nauheim. The city, located in the center of Germany, is a spa primarily dedicated to health care since centuries.

2003

PicoScan

PicoScan has been intro­duced to the market and allowed the (semi-​​) quanti­tative measure­ments of the Milenia QuickLine IL-​​6.

2003

ISO Certi­fi­cation

Milenia Biotec success­fully passed the first ISO audit by TÜV Rheinland and was granted a ISO certificate according to EN ISO 13485.

2006

First HybriDetect Publi­cation

The first scien­tific paper citing the use of Milenia HybriDetect in a molecular biology based method has been published by Piepenburg O. et al.

2008

POCScan

The POCScan instrument for the point-​​of-​​care measurement of Milenias lateral flow tests has been launched. It is the first true stand alone instrument available from Milenia Biotec. The first quanti­tative test available on POScan is Milenia QuickLine IL-​​6.

2011

Antigen and Antibody Devel­opment

Milenia Biotec opens an own R&D group dedicated to the devel­opment of antigens and antibodies.

2012

Bio-​​DrIM Network

Milenia Biotec joins the Bio-​​DrIM consortium, a group of European univer­sities and companies dealing with the biomarker driven person­alized immuno­sup­pression in trans­plant patients.

2013

ProAn­i­malLife Network

Milenia joins Network ProAn­i­malLife.

2014

Molecular Biology Test Devel­opment

Milenia Biotec opens R&D group dedicated to the devel­opment of molecular biology based PCR tests. The first project is the devel­opment of a series of PCR-​​tests for the detection of beer spoilage bacteria. All tests are based on Milenia HybriDetect our universal strip devel­opment platform.

2016

GenLine Detection of Beer Spoilage Bacteria

GenLine tests for the detection of beer spoilage bacteria launched to the market.

2017

Virus­Detect Project

Milenia receives research grants for the project „Virus­Detect“. The project is the contri­bution of Milenia to the network ProAn­i­malLife.

2018

GenLine Hygien­emon­i­toring

GenLine Hygien­emon­i­toring launched to the market.

2020

Milenia on LinkedIn

Milenia Biotec launches company page on LinkedIn.

2020

145 HybriDetect Publi­ca­tions

2000
2005
2010
2015
2020
2001

QuickLine IL-​​6

Milenia QuickLine IL-​​6, the first kit allowing a true point-​​of-​​care measurement of IL-​​6, has been launched by Milenia Biotec. The kit helped neona­tol­o­gists worldwide to improve the diagnosis of sepsis in preterm born infants and to create the basis to reduce unnec­essary antibiotic treat­ments and unnec­essary admis­sions to neonatal intensive care wards.

2003

HybriDetect

Milenia HybriDetect, has been released and became a core product of the company. Milenia HybriDetect is a universal lateral flow strip and serves for any developer as a simple rapid test devel­opment platform.

2005

HybriDetect 2T

Milenia HybriDetect 2T has been released to the market. The product allows the detection of two analytes on the same strip and is intended to be used for duplex testing in molecular biology based methods.

2008

Move to Gießen

Milenia Biotec moves from Bad Nauheim to Gießen, a university city with 84.000 inhab­i­tants, 45% of them are students. The university of Gießen/​Marburg with its medical faculty is in the close vicinity of the company.

2010

Gun Shot Residues

Milenias project „Detection of gun shot residues with a simple lateral flow test“ has been selected by the funding agency AiF as 1 of the 12 most innov­ative projects for their 2011 calender. AiF has selected the projects from more than 10.000 funded projects.

2011

QuickLine HIT

Milenia QuickLine HIT has been launched to the market. The test allows the exclusion of a heparin induced throm­bo­cy­topenia in patients at a suspision of a HIT on a very high level of sensi­tivity and speci­ficity.

2012

Medical App Devel­opment

Milenia Biotec opens an own R&D group dedicated to the devel­opment of medical apps.

2013

More Office Space

Milenia expands office floor space of the company building.

2015

Innovation Award to Cooper­ation Partner

German Brewers Associ­ation grants Innovation Award to Jennifer Koob, cooper­ation partner of Milenia in the project „Detection of beer spoilage bacteria with a simple lateral flow test“.

2017

GenLine Detection of Alicy­clobacilli

Milenia GenLine Alicy­clobacillus tests are launched to the market.

2017

First HybriDetect CRISPR Paper

First CRISPR based paper citing the use of Milenia HybriDetect published.

2020

Innovation Seal

Stifter­verband grants innovation seal to Milenia Biotec.

2020

HybriDetect and SARS-​​CoV-​​2

Milenia HybriDetect used in a series of papers for the detection of SARS-​​CoV-​​2.